Sensorion Logo

Sensorion

Clinical-stage biotech developing novel therapies for inner ear disorders and hearing loss.

ALSEN | PA

Overview

Corporate Details

ISIN(s):
FR0012596468 (+2 more)
LEI:
969500P0W8XJ9CGZDP97
Country:
France
Address:
375 RUE DU PROFESSEUR BLAYAC, 34080 MONTPELLIER

Description

Sensorion is a clinical-stage biotechnology company specializing in the development of novel therapies for inner ear disorders. The company's mission is to address the significant unmet medical need of hearing loss by creating innovative therapeutic solutions. Its strategy is built on three pillars: restoring hearing through gene therapies for genetic diseases, treating existing hearing disorders with small molecule therapeutics, and preventing non-genetic hearing loss, such as drug-induced ototoxicity. Sensorion utilizes a unique R&D technology platform to advance its understanding of the pathophysiology of inner ear diseases and develop its pipeline of clinical candidates.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-19 07:30
Inside Information / Other news releases
English 172.3 KB
2025-12-19 07:30
Informations privilégiées / Autres communiqués
French 174.6 KB
2025-12-08 07:30
Inside Information / Other news releases
English 216.7 KB
2025-12-08 07:30
Informations privilégiées / Autres communiqués
French 234.1 KB
2025-09-17 07:30
Inside Information / News release on accounts, results
English 253.3 KB
2025-09-17 07:30
Informations privilégiées / Communiqué sur comptes, résultats
French 273.6 KB
2025-09-04 07:30
Inside Information / Other news releases
English 168.5 KB
2025-09-04 07:30
Informations privilégiées / Autres communiqués
French 174.1 KB
2025-08-15 07:30
Inside Information / Other news releases
English 139.2 KB
2025-08-15 07:30
Informations privilégiées / Autres communiqués
French 140.2 KB
2025-07-31 09:17
Inside Information / Other news releases
English 193.1 KB
2025-07-31 09:17
Informations privilégiées / Autres communiqués
French 186.2 KB
2025-07-29 07:30
Inside Information / Other news releases
English 188.2 KB
2025-07-29 07:30
Informations privilégiées / Autres communiqués
French 192.0 KB
2025-07-01 07:30
Inside Information / Other news releases
English 187.9 KB

Automate Your Workflow. Get a real-time feed of all Sensorion filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sensorion

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sensorion via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-04-11 N/A Other Other 2,781,914 1,752,605.82 EUR
2024-04-11 N/A Other Other 1,587,301 999,999.63 EUR
2024-02-13 N/A Other Other 16,842,105 9,599,999.85 EUR
2024-02-08 N/A Other Other 12,280,701 6,999,999.57 EUR
2023-08-08 N/A Other Other 46,428,571 12,999,999.88 EUR
2023-08-03 N/A Other Other 25,000,000 7,000,000.00 EUR

Peer Companies

Transgene Logo
Develops cancer immunotherapies using vaccines and oncolytic viruses.
France
TNG
TRANS GENIC GROUP INC. Logo
Biotech firm offering drug discovery support and investment/consulting services.
Japan
2342
TriSalus Life Sciences, Inc. Logo
Oncology company integrating drug delivery with immunotherapy to treat solid tumors.
United States of America
TLSI
TScan Therapeutics, Inc. Logo
A clinical-stage biotech developing TCR-engineered T cell therapies for cancer.
United States of America
TCRX
Tsubota Laboratory Incorporated Logo
R&D company developing treatments for ophthalmology and CNS disorders.
Japan
4890
TuHURA Biosciences, Inc./NV Logo
A Phase 3 immuno-oncology company developing therapies for immunotherapy resistance.
United States of America
HURA
Tyra Biosciences, Inc. Logo
Clinical-stage biotech developing precision medicines targeting FGFR biology.
United States of America
TYRA
UCAR Logo
A nonprofit consortium of universities advancing atmospheric and Earth system sciences.
France
ALUCR
Ulisse Biomed Logo
Develops an integrated platform for distributed and connected diagnostic solutions.
Italy
UBM
UNIVERSAL DISPLAY CORP \PA\ Logo
Researches, develops, and supplies OLED technologies and materials for displays.
United States of America
OLED

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.